We are pleased to announce the commercialization of “N-NOSE plus Pancreas”, the world’s first cancer type specific test, the next generation of the N-NOSE nematode cancer test.
“N-NOSE plus Pancreas”, the world’s first test to detect early-stage pancreatic cancer, is now available for practical use.
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20
HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. －Pre-order available, special discounts ar . . .2023.03.10
Our CEO made a courtesy call on Minister Yasutoshi Nishimura.2023.02.27